2227
However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .
 Disease: MCL; Chemical: temsirolimus; Disease: MCL; Disease: tumor; Chemical: temsirolimus
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Disease: MCL; Chemical: temsirolimus; Disease: MCL; Disease: tumor; Chemical: temsirolimus